HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
During the third quarter of fiscal year 2025 (“Q3 FY2025”) and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant ...
Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused ...